Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
2018-06-05
Source PublicationFRONTIERS IN AGING NEUROSCIENCE
ISSN1663-4365
Volume10
Status已发表
DOI10.3389/fnagi.2018.00169
AbstractAlzheimer's disease (AD) is a multi-factorial neurodegenerative disorder with abnormal accumulation of amyloid-beta (A beta) plaques, neuroinflammation and impaired neurogenesis. Mounting evidences suggest that single-target drugs have limited effects on clinical treatment and alternative or multiple targets are required. In recent decades, natural compounds and their derivatives have gained increasing attention in AD drug discovery due to their inherently enormous chemical and structural diversity. In this study, we demonstrated that naringin dihydrochalcone (NDC), a widely used dietary sweetener with strong antioxidant activity, improved the cognitive function of transgenic AD mice. Pathologically, NDC attenuated A beta deposition in AD mouse brain. Furthermore, NDC reduced periplaque activated microglia and astrocytes, indicating the inhibition of neuroinflammation. It also enhanced neurogenesis as investigated by BrdU/NeuN double labeling. Additionally, the inhibition of Ab level and neuroinflammation by NDC treatment was also observed in an AD cell model or a microglia cell line. Taken together, our study indicated that NDC might be a potential therapeutic agent for the treatment of AD against multiple targets that include A beta pathology, neuroinflammation and neurogenesis.
Keywordnaringin dihydrochalcone Alzheimer's disease amyloid-beta neuroinflammation neurogenesis
Indexed BySCI ; SCIE
Language英语
Funding ProjectShanghai Municipal Commission for Science and Technology[15JC1400202]
WOS Research AreaGeriatrics & Gerontology ; Neurosciences & Neurology
WOS SubjectGeriatrics & Gerontology ; Neurosciences
WOS IDWOS:000434155000001
PublisherFRONTIERS MEDIA SA
WOS KeywordADULT HIPPOCAMPAL NEUROGENESIS ; A-BETA LEVELS ; ALZHEIMERS-DISEASE ; VITAMIN-E ; AMYLOID DEPOSITION ; MOUSE MODEL ; CURCUMIN ; MEMORY ; TRIAL ; NEUROINFLAMMATION
Original Document TypeArticle
Citation statistics
Document Type期刊论文
Identifierhttps://kms.shanghaitech.edu.cn/handle/2MSLDSTB/23083
Collection生命科学与技术学院
生命科学与技术学院_特聘教授组_裴钢组
生命科学与技术学院_硕士生
Corresponding AuthorHuang, Shichao; Pei, Gang
Affiliation
1.Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Chinese Acad Sci, Shanghai, Peoples R China
2.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
3.Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol, Lab Receptor Based Biomed, Shanghai, Peoples R China
4.Tongji Univ, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China
Recommended Citation
GB/T 7714
Yang, Wenjuan,Zhou, Keyan,Zhou, Yue,et al. Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice[J]. FRONTIERS IN AGING NEUROSCIENCE,2018,10.
APA Yang, Wenjuan.,Zhou, Keyan.,Zhou, Yue.,An, Yuqian.,Hu, Tingting.,...&Pei, Gang.(2018).Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice.FRONTIERS IN AGING NEUROSCIENCE,10.
MLA Yang, Wenjuan,et al."Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice".FRONTIERS IN AGING NEUROSCIENCE 10(2018).
Files in This Item: Download All
File Name/Size DocType Version Access License
Related Services
Usage statistics
Scholar Google
Similar articles in Scholar Google
[Yang, Wenjuan]'s Articles
[Zhou, Keyan]'s Articles
[Zhou, Yue]'s Articles
Baidu academic
Similar articles in Baidu academic
[Yang, Wenjuan]'s Articles
[Zhou, Keyan]'s Articles
[Zhou, Yue]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Yang, Wenjuan]'s Articles
[Zhou, Keyan]'s Articles
[Zhou, Yue]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: 10.3389@fnagi.2018.00169.pdf
Format: Adobe PDF
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.